Lemaitre Vascular (LMAT) Operating Margin (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Operating Margin came in at 26.71% in Q1 2026, up 562.0% year-on-year from 4.03% in Q1 2025, and down 8.59% on a QoQ basis from 29.22% in Q4 2025.
Lemaitre Vascular (LMAT) Operating Margin (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Operating Margin data on file, last reported at 26.71% in Q1 2026.
- On a quarterly basis, Operating Margin rose 562.0% year-over-year to 26.71% in Q1 2026; TTM through Mar 2026 was 28.51%, a 508.0% increase from a year earlier, with the FY2025 full-year figure at 27.21%, up 344.0% from the prior year.
- Operating Margin for Q1 2026 stood at 26.71%, down from 29.22% in the prior quarter.
- Over the last five years, Operating Margin for LMAT reached as high as 33.27% in Q3 2025 and fell as low as 13.74% in Q2 2022.
- Historically, Operating Margin has averaged 21.93% across 5 years, with a median of 21.09% in 2025.
- Across the five-year window, Operating Margin sank 1357 bps in 2022 and soared 929 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 17.01% in 2022, then climbed by 23 bps to 20.88% in 2023, then advanced by 10 bps to 23.07% in 2024, then grew by 27 bps to 29.22% in 2025, then slipped by 9 bps to 26.71% in 2026.
- Per Business Quant data, the three most recent Operating Margin figures were 26.71% in Q1 2026, 29.22% in Q4 2025, and 33.27% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn | 26.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.71% |
| Dec 31, 2025 | 29.22% |
| Sep 30, 2025 | 33.27% |
| Jun 30, 2025 | 25.13% |
| Mar 31, 2025 | 21.09% |
| Dec 31, 2024 | 23.07% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | 25.75% |
| Mar 31, 2024 | 22.20% |
| Dec 31, 2023 | 20.88% |
| Sep 30, 2023 | 19.36% |
| Jun 30, 2023 | 18.86% |
| Mar 31, 2023 | 16.73% |
| Dec 31, 2022 | 17.01% |
| Sep 30, 2022 | 15.76% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | 20.04% |
| Dec 31, 2021 | 21.01% |
| Sep 30, 2021 | 23.65% |
| Jun 30, 2021 | 27.31% |